| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 139.22B | 129.00B | 141.60B | 148.97B | 137.66B | 138.38B |
| Gross Profit | 34.64B | 32.18B | 35.41B | 36.93B | 33.54B | 32.79B |
| EBITDA | 9.58B | 7.96B | 9.89B | 14.90B | 8.26B | 7.11B |
| Net Income | 4.13B | 2.68B | 4.31B | 7.34B | 3.26B | 2.10B |
Balance Sheet | ||||||
| Total Assets | 93.61B | 101.52B | 98.01B | 95.39B | 87.93B | 98.07B |
| Cash, Cash Equivalents and Short-Term Investments | 12.16B | 15.65B | 16.74B | 21.34B | 18.12B | 22.30B |
| Total Debt | 12.79B | 15.93B | 13.18B | 5.58B | 7.67B | 10.22B |
| Total Liabilities | 36.48B | 42.92B | 41.36B | 37.90B | 36.91B | 49.75B |
| Stockholders Equity | 57.12B | 58.59B | 56.64B | 57.48B | 49.20B | 46.64B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.33B | -8.22B | 3.85B | -727.00M | 9.19B |
| Operating Cash Flow | 0.00 | 6.41B | 4.92B | 11.19B | 3.10B | 11.46B |
| Investing Cash Flow | 0.00 | -8.68B | -12.57B | -4.55B | -3.82B | -2.75B |
| Financing Cash Flow | 0.00 | 1.18B | 3.06B | -3.42B | -3.47B | -3.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥817.70B | 19.74 | 19.13% | 2.64% | 9.45% | 12.93% | |
64 Neutral | ¥132.84B | 11.41 | ― | 2.82% | 13.31% | -11.40% | |
63 Neutral | ¥29.44B | 12.39 | ― | 4.79% | -8.90% | -31.83% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥52.40B | 11.80 | ― | 4.49% | 10.55% | -5.43% | |
53 Neutral | ¥277.68B | 17.73 | ― | 1.24% | 19.04% | 108.13% | |
49 Neutral | ¥3.60B | 21.74 | ― | 1.08% | -0.94% | ― |